Large study finds that Ivermectin has no reducing effect on the risk of COVID-19 hospitalization

The anti-parasitic drug ivermectin, despite lacking strong research to support it, has surged in popularity as an "alternate" treatment for COVID-19. A study published on Wednesday compared more than 1,300…

Continue ReadingLarge study finds that Ivermectin has no reducing effect on the risk of COVID-19 hospitalization

FDA authorizes second bosoter dose for adults 50 years old an immunocompromised people

On Tuesday, the US Food and Drug Administration signed off on a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and some immunocompromised…

Continue ReadingFDA authorizes second bosoter dose for adults 50 years old an immunocompromised people